Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis
ObjectiveTo compare the short-term efficacy and safety of efgartigimod versus intravenous immunoglobulin (IVIg) in patients with impending myasthenic crisis (IMC).MethodsThis single-center, randomized, open-label, prospective comparative cohort study included 38 acetylcholine receptor antibody–posit...
שמור ב:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2026-03-01
|
| סדרה: | Frontiers in Immunology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1760953/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|